Director of Medical Affairs Scientific Communication

About Celea Therapeutics Celea Therapeutics is dedicated to advancing transformative treatments for people with serious respiratory diseases. Drawn from the Latin word for “sky,” our name reflects our mission to rise above the status quo and deliver therapies that change lives. Our lead program, deupirfenidone (LYT-100), is currently in Phase 3 clinical development with active candidate enrollment, representing a potential new standard of care for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases. Rising above the status quo takes a team as strong as its science, and we hire and work by five values: accountability — owning outcomes and acting like owners; transparency — talking straight and building trust; collaboration — achieving together what no one could alone; innovation — challenging accepted ideas and taking smart risks; and passion — bringing energy and heart to the mission. Position Overview The Director of Medical Affairs Scientific Communications is a strategic and execution-focused leader responsible for developing and delivering high-quality, scientifically rigorous communication strategies across Celea Therapeutics’ portfolio. This role will drive the creation of medical content that supports internal and external stakeholders, including healthcare professionals, payers, and patients. The Director will partner cross-functionally with Clinical Development, Regulatory Affairs, Commercial, and external experts to ensure the accurate, compliant, and impactful dissemination of scientific data. This individual will play a critical role in shaping the scientific narrative, supporting product lifecycle strategies, and enhancing the company’s credibility within the medical and scientific community. Key Responsibilities Define and own the strategic development and implementation for the Medical Affairs communication and educational activities, including long term scientific narrative, publication roadmap and stakeholder engagement plan. Establish and govern the global publication strategy, including prioritization of data dissemination, authorship strategy and alignment with clinical and regulatory milestones. Oversee and guide IPF/pulmonary fibrosis Congress planning, submission of publications, and on-site medical affairs activities. Provide strategic direction on development of manuscripts for peer-review journals. Lead development of a scientific communication platform and lexicon for deupirfenidone. Manage a core educational slide deck for disease state and the deupirfenidone development program to be used in investigator meetings, site initiation visits, internal and external training, physician referral outreach. Maintain a patient-facing educational slide deck to be used in support group and advocacy outreach. Define and execute KOL engagement strategy, including identification, segmentation and long-term relationship planning to inform development and scientific communication efforts. Oversee the strategy and execution of scientific advisory boards, ensuring meaningful expert engagement and actionable insights. Create and lead a Medical Affairs Review Committee for all Medical Affairs information and educational materials and conduct medical reviews of external communications. Initiate medical information strategy and content development including scientific responses, FAQs, compendia reviews, literature summaries for annual reports, and scientific congress coverage. Provide cross functional support for clinical development as needed, including training, educational materials, content for CSRs and other documents. Support site initiation visits (virtual or on site) to ensure scientific understanding of the deupirfenidone program. Provide support for development and implementation of policies, procedures, and processes for Medical Affairs. Serve as the Medical Affairs communications lead across cross functional teams (Clinical, Regulatory, HEOR, Commercial), ensuring alignment of scientific narrative and data dissemination strategy. Qualifications Advanced clinical and scientific training/experience required equivalent to PharmD, PhD, MD or other advanced degree. Minimum of 5 years Medical Communications experience with 8+ years in the pharmaceutical/ biotechnology industry, including demonstrated experience leading publication strategy, scientific communications planning and cross functional collaboration. Understanding of and adherence to legal, regulatory and compliance policies governing scientific interactions. Experience with data management and informatics. Exceptional organizational/project management skills. Must be able to determine new needs, develop solutions, and lead processes through to operational excellence. An outstanding track record of strong communication, presentation, analytic and strategic capabilities and ability to effectively collaborate with internal and external partners. Ability to thrive in a fast-paced, entrepreneurial, results oriented environment with busy, high performing colleagues. Demonstrated ability to function at a high level in a team setting whether leading the group or acting as an individual contributor. Mastery of English (written and spoken). Note this position requires US and international travel (~25%). Entrepreneurial mindset and comfort operating in a fast-paced, early-stage environment. Why Join Celea Therapeutics Play a pivotal role in advancing life-changing therapies for patients with devastating lung diseases Shape the financial and strategic foundation of a Phase 3–ready biotech poised for significant growth Collaborate with a passionate, mission-driven leadership team Competitive compensation and equity package Actual compensation will be determined based on experience, qualifications, and location. In addition to base pay, this role is eligible for bonus and equity compensation. Base Pay Information: $245,000 USD - $310,000 USD Our Commitment Celea Therapeutics is an equal opportunity employer. We evaluate every candidate against the requirements of the role using a structured, evidence-based process, and we make employment decisions without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other legally protected characteristic. For more information, visit or connect with us on Twitter @celeatx. #J-18808-Ljbffr Celea Therapeutics